PuSH - Publication Server of Helmholtz Zentrum München

24 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
Khajavi, N.* et al.: Tri-agonist-induced PLC activation is associated with robust insulin secretion from murine islets. Naunyn-Schmiedebergs Arch. Pharmakol. 392, S35-S35 (2019)
Khajavi, N.* et al.: An incretin-based tri-agonist promotes superior insulin secretion from murine pancreatic islets via PLC activation. Cell. Signal. 51, 13-22 (2018)
Khajavi, N.* ; Biebermann, H.* ; Tschöp, M.H. & DiMarchi, R.*: Treatment of diabetes and obesity by rationally designed peptide agonists functioning at multiple metabolic receptors. In: (10th ESPE Advanced Seminar in Developmental Endocrinology, 10 June 2016, Ulm). 2017. 165-182 (Endocr. Dev. ; 32)
Finan, B. et al.: Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic Impact for metabolic disease. Cell 167, 843-857.e14 (2016)
Müller, A.* et al.: Ring finger protein 11 inhibits melanocortin 3 and 4 receptor signaling. Front. Endocrin. 7:109 (2016)
Dinter, J.* et al.: Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5. PLoS ONE 10:e0117774 (2015)
Heppner, K.M.* et al.: Both acyl and des-acyl ghrelin regulate adiposity and glucose metabolism via CNS ghrelin receptors. Diabetes 63, 122-131 (2014)
Knoll, N.* et al.: Mitochondrial DNA variants in obesity. PLoS ONE 9:e94882 (2014)
Mühlhaus, J.* et al.: Analysis of human TAAR8 and murine Taar8b mediated signaling pathways and expression profile. Int. J. Mol. Sci. 15, 20638-20655 (2014)
Mühlhaus, J.* et al.: Aspects of 3-iodothyronamine (3T1AM) induced signaling by human and mouse trace amine-associated receptor 5 (TAAR5). Exp. Clin. Endocrinol. Diabet. 122:OP7_38 (2014)
Müller, A.* et al.: The extracellular N-terminal domain of G-protein coupled receptor 83 regulates signaling properties and is an intramolecular inverse agonist. BMC Res. Notes 7:913 (2014)
Bolze, F.* et al.: Characterization of the melanocortin-4-receptor nonsense mutation W16X in vitro and in vivo. Pharmacogenomics J. 13, 80-93 (2013)
Müller, A.* et al.: G-Protein coupled Receptor 83 (GPR83) signaling determined by constitutive and zinc(II)-induced activity. PLoS ONE 8:e53347 (2013)
Müller, T.D. et al.: The orphan receptor Gpr83 regulates systemic energy metabolism via ghrelin-dependent and ghrelin-independent mechanisms. Nat. Commun. 4:1968 (2013)
Mühlhaus, J.* et al.: Do common variants separate between obese melanocortin-4 receptor gene mutation carriers and non-carriers? The impact of cryptic relatedness. Horm. Res. Paediatr. 77, 358-368 (2012)
Volckmar, A.-L.* et al.: Mutation screen in the GWAS derived obesity gene SH2B1 including functional analyses of detected variants. BMC Med. Genomics 5:65 (2012)
Sauber, J.* et al.: Association of variants in gastric inhibitory polypeptide receptor gene with impaired glucose homeostasis in obese children and adolescents from Berlin. Eur. J. Endocrinol. 163, 259-264 (2010)
Scherag, A.* et al.: Two new loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and German study groups. PLoS Genet. 6:e1000916 (2010)
Speliotes, E.K.* et al.: Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42, 937-948 (2010)
Heid, I.M. et al.: Meta-analysis of the INSIG2 association with obesity including 74,345 individuals: Does heterogeneity of estimates relate to study design? PLoS Genet. 5:e1000694 (2009)